Delicious
Digg
Facebook
LinkedIn
Twitter
Webcasts & Presentations
| Featured Event | |||
|---|---|---|---|
|
4:30 PM ET |
OncoGenex First Quarter 2013 Conference Call
|
||
| Upcoming Events |
|---|
| Details on upcoming events are not yet available. Please click here to be notified of all upcoming events. |
| Archived Events | |||||
|---|---|---|---|---|---|
|
9:30 AM ET |
Future Leaders in the Biotech Industry Conference
|
||||
|
4:30 PM ET |
OncoGenex Fourth Quarter 2012 Conference Call
|
||||
|
11:30 AM ET |
RBC Capital Markets Global Healthcare Conference
|
||||
|
2:30 PM ET |
Leerink Swann Global Healthcare Conference
|
||||
|
1:00 PM ET |
15th Annual BIO CEO & Investor Conference
|
||||
|
10:00 AM ET |
Lazard Capital Markets 9th Annual Healthcare Conference
|
||||
|
4:30 PM ET |
OncoGenex Third Quarter 2012 Conference Call
|
||||
|
|
A Randomized Phase II Study of OGX-427 + Prednisone vs. Prednisone Alone in Patients with Chemotherapy-Naive Metastatic Castration Resistant Prostate Cancer
|
||||
|
2:25 PM ET |
Rodman & Renshaw Annual Global Investment Conference
|
||||
|
10:55 AM ET |
Stifel Nicolaus Annual Healthcare Conference
|
||||
|
4:30 PM ET |
OncoGenex Second Quarter 2012 Conference Call
|
||||
|
|
ASCO 2012: A randomized Phase 2 study of OGX-427 plus prednisone in CRPC
|
||||
|
|
OncoGenex First Quarter 2012 Conference Call
|
||||
|
10:30 AM ET |
Future Leaders in the Biotech Industry Conference
|
||||
|
10:00 AM ET |
11th Annual Needham Healthcare Conference
|
||||
|
|
OncoGenex Fourth Quarter 2011 Conference Call
|
||||
|
1:30 PM ET |
Cowen Annual Health Care Conference
Speaker: Scott Cormack, Chief Executive Officer
|
||||
|
8:00 AM ET |
RBC Capital Markets Global Healthcare Conference
Speaker: Scott Cormack, Chief Executive Officer
|
||||
|
4:00 PM ET |
Citi Global Health Care Conference
Speaker: Scott Cormack, Chief Executive Officer
|
||||
|
|
27th Annual European Association of Urology Congress
|
||||
|
11:30 AM ET |
Leerink Swann Global Healthcare Conference
Speaker: Scott Cormack, Chief Executive Officer
|
||||
|
8:30 AM ET |
BIO CEO & Investor Conference
Speaker: Scott Cormack, Chief Executive Officer
|
||||
|
|
OGXI BIO CEO presentation 2.14.12
|
||||
|
6:35 PM PT |
ASCO 2012 Genitourinary Cancers Symposium Presentation
|
||||
|
|
ASCO GU 2012 OGX-427 posters | ||||
|
4:30 PM ET |
OGX-011 Abstract Presentation at American Society of Clinical Oncology (ASCO) Annual Meeting
|
||||
© 2004-2011 OncoGenex Pharmaceuticals Inc. All rights reserved.
OncoGenex product candidates are investigational drugs for use only in approved clinical trials.